BlackRock Investment Management’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

BlackRock Investment Management’s Portfolio DMK Stock Details DMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9K	Hold	40	–	–	﹤0.01%	3633
2016 Q3	$10K	Buy	40 +9	+29%	+$1.87K	﹤0.01%	3599
2016 Q2	$6K	Sell	31 -2	-6%	-$922	﹤0.01%	3825
2016 Q1	$14K	Hold	33	–	–	﹤0.01%	3493
2015 Q4	$12K	Buy	33 +1	+3%	+$313	﹤0.01%	3620
2015 Q3	$9K	Hold	32	–	–	﹤0.01%	3741
2015 Q2	$9K	Hold	32	–	–	﹤0.01%	3778
2015 Q1	$9K	Buy	32 +6	+23%	+$2.59K	﹤0.01%	3703
2014 Q4	$11K	Hold	26	–	–	﹤0.01%	3653
2014 Q3	$8K	Hold	26	–	–	﹤0.01%	3766
2014 Q2	$9K	Buy	+26	New	+$10.2K	﹤0.01%	3678

Other funds holding DMK

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LCM

Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SGS

Sterling Global Strategies Carlsbad, California $18M AUM 11.58% 1-Year Est. Return

BlackRock Investment Management's DMK Position: Q4 2016 in Review

BlackRock Investment Management held its DMK Pharmaceuticals Corporation Common Stock (DMK) position steady in Q4 2016 at 40 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #3633.

BlackRock Investment Management first reported a position in DMK in Q2 2014 and has held it in 11 quarters since. The position peaked at $14K in Q1 2016. 35 funds tracked by Wall St. Rank hold DMK as of Q4 2016.

BlackRock Investment Management held 40 shares of DMK Pharmaceuticals Corporation Common Stock worth $9K as of Q4 2016.
BlackRock Investment Management left its DMK Pharmaceuticals Corporation Common Stock share count unchanged in Q4 2016.
DMK Pharmaceuticals Corporation Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3633 holding.
BlackRock Investment Management first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's DMK Pharmaceuticals Corporation Common Stock position peaked at $14K in Q1 2016.
35 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.